Governance Ocugen, Inc.

OCGN

US67577C1053

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2026 am IST			5-day change	1st Jan Change
1.280 ^USD	-6.57%		-7.25%	-5.19%

04/06	Ocugen, Inc. Announces Executive Changes, Effective May 29, 2026	CI
15/05	Ocugen Closes Offering of Senior Notes Due 2034	MT

Executive Committee: Ocugen, Inc.

Manager

Positions heldSince

Shankar Musunuri

62 year

Chief Executive Officer	27/09/2019
Founder	01/01/2013

Rita Johnson-Greene

Comptroller/Controller/Auditor	03/06/2026
Director of Finance/CFO	09/02/2026

Kristen Craft

Human Resources Officer

Jyothy Pillai

General Counsel	-
Corporate Officer/Principal	-

John Kouch

General Counsel	-
Corporate Secretary	-

Michael Breininger

44 year

Comptroller/Controller/Auditor

01/08/2023

Jesse Simmers

Chief Tech/Sci/R&D Officer

Arun Upadhyay

44 year

Chief Tech/Sci/R&D Officer

01/12/2020

Mohamed Genead

Chief Tech/Sci/R&D Officer

08/05/2026

Composition of the Board of Directors: Ocugen, Inc.

Director

CommitteesSince

Shankar Musunuri

62 year

Chairman

27/09/2019

Kirsten Castillo

53 year

Audit Committee	05/04/2020
Compensation Committee
Governance Committee Chair	06/10/2020
Nominating Committee Chair	06/10/2020

Uday Kompella

59 year

Compensation Committee	01/09/2013
Governance Committee	27/09/2019
Nominating Committee	27/09/2019

Junge Zhang

59 year

Governance Committee	01/09/2019
Nominating Committee	01/09/2019

Blaise Coleman

52 year

Director/Board Member

05/06/2025

C. Satish Chandran

70 year

Director/Board Member

05/06/2025

Latest Appointments: Ocugen, Inc.

04/06	Ocugen, Inc. Announces Executive Changes, Effective May 29, 2026	CI
15/05	Ocugen, Inc. Announces Chief Medical Officer Changes, Effective May 8, 2026	CI
09/02	Ocugen, Inc. Announces Executive Changes, Effective February 9, 2026	CI
09/02	Ocugen Names Rita Johnson-Greene as CFO	MT
09/02	Ocugen appoints Rita Johnson-Greene to chief financial officer	RE
21/25/21	Ocugen, Inc. Announces Appointments to Retina Scientific Advisory Board & Executive Leadership Team	CI
26/25/26	Ocugen, Inc. Announces Directorate Resignations	CI

More news

Former Officers and Directors: Ocugen, Inc.

Insider

Positions held

SinceUntil

Ramesh Ramachandran

Comptroller/Controller/Auditor	01/09/2024	29/05/2026
Director of Finance/CFO	14/11/2024	09/02/2026

Huma Qamar

Chief Tech/Sci/R&D Officer	18/03/2024	08/05/2026
Corporate Officer/Principal	-	18/03/2024

Michael Shine

Corporate Officer/Principal

10/06/2021

21/07/2025

Prabhavathi Fernandes

Director/Board Member	05/04/2020	05/06/2025
Independent Dir/Board Member	05/04/2020	05/06/2025

Marna Whittington

Director/Board Member	17/03/2022	05/06/2025
Independent Dir/Board Member	17/03/2022	05/06/2025

Ramesh Kumar

Comptroller/Controller/Auditor	-	15/09/2023
Director/Board Member	27/09/2019	28/06/2024
Independent Dir/Board Member	27/09/2019	28/06/2024

Robert J. Hopkins

Chief Tech/Sci/R&D Officer

01/09/2022

18/03/2024

Zara Gaudioso

Human Resources Officer

01/03/2021

01/10/2023

Quan Anh Vu

Comptroller/Controller/Auditor	10/03/2023	14/08/2023
Director of Finance/CFO	06/03/2023	14/08/2023
Corporate Officer/Principal	01/02/2023	06/03/2023

Jessica Crespo

Comptroller/Controller/Auditor	23/10/2019	10/03/2023
Director of Finance/CFO	18/03/2022	06/03/2023
Treasurer	23/10/2019	18/03/2022

J.P. Gabriel

Corporate Officer/Principal

01/01/2022

01/09/2022

Manish Potti

Director/Board Member	27/09/2019	07/06/2022
Independent Dir/Board Member	27/09/2019	07/06/2022

Kenneth Inchausti

Investor Relations Contact	21/06/2021	01/06/2022
Public Communications Contact	21/06/2021	01/06/2022

Sanjay Subramanian

Director of Finance/CFO	01/10/2019	18/03/2022
Investor Relations Contact	-	-
Corporate Secretary	01/06/2020	18/03/2022

Suha Halit Taspolatoglu

Director/Board Member	27/09/2019	10/12/2021
Independent Dir/Board Member	27/09/2019	10/12/2021

Rasappa Arumugham

Chief Tech/Sci/R&D Officer

01/03/2017

31/12/2020

Bruce D. Forrest

Chief Tech/Sci/R&D Officer

01/12/2020

Daniel M. Jorgensen

Chief Tech/Sci/R&D Officer

01/04/2017

15/07/2020

Kelly Beck

Chief Administrative Officer	01/07/2017	01/06/2020
Investor Relations Contact	01/07/2017	01/06/2020

Frank Leo

Director/Board Member	27/09/2019	03/04/2020
Independent Dir/Board Member	27/09/2019	03/04/2020

Susan Drexler

Director of Finance/CFO

01/04/2018

01/06/2019

Nirdosh Jagota

Compliance Officer	-	-
General Counsel	-	-

Andrew Walsh

Corporate Officer/Principal	-	-
Treasurer	-	-

Age distribution of managers

Parity Men Women

Male	13
Female	5

Of which Executive Committee

Male	6
Female	3

Of which Directors

Male	5
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Employees

116

Sector

Biotechnology & Medical Research

More about the company